Show Summary Details
Page of

Systemic lupus erythematosus (SLE) in pregnancy 

Systemic lupus erythematosus (SLE) in pregnancy
Systemic lupus erythematosus (SLE) in pregnancy

Aisha Lateef

and M. Petri

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 August 2020

1. Pregnancy in SLE is associated with increased maternal and foetal morbidity including disease flares, foetal loss, prematurity, IUGR and pre-eclampsia.

2. Disease flares are more common during pregnancy.

3. Disease activity at the time of conception is associated with poor outcomes.

4. Pre-conception assessment is necessary to risk-stratify the patients.

5. Differentiation between renal flares and pre-eclampsia may be difficult in some cases.

6. Pre-term births are frequent in SLE pregnancies. The combination of highly active clinical lupus and abnormal serological tests (low complement, high anti-dsDNA) is most predictive of pre-term birth.

7. Pharmacotherapy during pregnancy needs to be adjusted for the safety of the mother and foetus.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.